Abstract:Introduction: Infantile Hemangioma (IH) is a prevalent benign vascular tumor affecting approximately 5-10% of infants. Its underlying pathogenesis remains enigmatic, and current therapeutic approaches show limited effectiveness. Our study aimed to discover potential IH-associated therapeutics through a transcriptomic, computational drug repurposing methodology. Methods: Utilizing the IH-specific dataset GSE127487 from the Gene Expression Omnibus, we identified differentially expressed genes (DEGs) and conducted weighted gene coexpression network analysis (WGCNA). Subsequently, a protein-protein interaction (PPI) network was constructed to obtain the top 100 hub genes. Drug candidates were sourced from the Connectivity Map (CMap) and Comparative Toxicogenomics Database (CTD). Results: Our analysis revealed 1203 DEGs and a significant module of 1780 mRNAs strongly correlated with IH. These genes were primarily enriched in the PI3K/AKT/MTOR, RAS/MAPK, and CGMP/PKG signaling pathway. After creating a PPI network of overlapping genes, we filtered out the top 100 hub genes. Ultimately, 44 non-toxic drugs were identified through the CMap and CTD databases. Twelve molecular-targeting agents (belinostat, chir 99021, dasatinib, entinostat, panobinostat, sirolimus, sorafenib, sunitinib, thalidomide, U 0126, vorinostat, and wortmannin) may be potential candidates for IH therapy. Moreover, in vitro experiments demonstrated that entinostat, sorafenib, dasatinib, and sirolimus restricted the proliferation and migration and initiated apoptosis in HemEC cells, thereby underscoring their potential therapeutic value. Conclusion: Our investigation revealed that the pathogenic mechanism underlying IH might be closely associated with the PI3K/AKT/MTOR, RAS/MAPK, and CGMP/PKG signaling pathways. Furthermore, we identified twelve molecular-targeting agents among the predicted drugs that show promise as therapeutic candidates for IH.

Long Noncoding RNA Expression Profile of Infantile Hemangioma Identified by Microarray Analysis

Non-coding RNA in infantile hemangioma

Expression profile of circular RNAs in infantile hemangioma detected by RNA-Seq.

Construction of Mirna-Mrna Regulatory Network to Identify Potential Biomarkers in Infantile Hemangioma by Integrated Bioinformatics Analysis

Identifying Potential Diagnostic and Therapeutic Targets for Infantile Hemangioma Using WGCNA and Machine Learning Algorithms

Silencing long non‑coding RNA NEAT1 suppresses the tumorigenesis of infantile hemangioma by competitively binding miR‑33a‑5p to stimulate HIF1α/NF‑κB pathway

ALKBH5 promotes the progression of infantile hemangioma through regulating the NEAT1/miR-378b/FOSL1 axis

Identification of Novel Potential Biomarkers in Infantile Hemangioma Via Weighted Gene Co-Expression Network Analysis

LncRNA-TUG1 promotes the progression of infantile hemangioma by regulating miR-137/IGFBP5 axis

Transcriptional data analysis reveals the association between infantile hemangiomas and venous malformations

Integrated WGCNA and PPI Network to Screen Hub Genes Signatures for Infantile Hemangioma

Identification of Potential Therapeutics for Infantile Hemangioma via in silico Investigation and in vitro Validation

Signaling pathways in the development of infantile hemangioma

A novel hsa_circ_0006903 circular RNA promotes tumor development and dendritic cells activated expression in infantile hemangioma

Long Non-Coding RNA NEAT1 Promotes the Progression of Hemangioma Via the Mir-361-5p/vegfa Pathway

Long non-coding RNA expression in neonatal rat brain tissue after hypoxic-ischemic injury

Analysis of Long Non-Coding RNA expression profiles in neonatal rats with hypoxic-ischemic brain damage.

[Indentification of Differentially Expressed Genes in Proliferating and Involuting Hemangiomas by Cdan Microarray Analysis of Gene-Expression Profiles].

Angiogenin: a potential serum marker of infantile hemangioma revealed by cDNA microarray analysis.

LncRNA OIP5-AS1 Promotes the Proliferation of Hemangioma Vascular Endothelial Cells Via Regulating Mir-195-5p/nob1 Axis

Characterization of epigenetic and transcriptional landscape in infantile hemangiomas with ATAC-seq and RNA-seq